Cover Image

Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study

Abstract Background Type 2 diabetes mellitus is a chronic disease affecting millions of people worldwide. Achieving and maintaining glycemic control is essential to prevent or delay complications and different strategies are available as second-line treatment options for patients with type 2 diabete...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dan Ouchi (Author), Carles Vilaplana-Carnerero (Author), Ramon Monfà (Author), Maria Giner-Soriano (Author), Ana Garcia-Sangenís (Author), Ferran Torres (Author), Rosa Morros (Author)
Format:	Book
Published:	Adis, Springer Healthcare, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sex and gender differences in the use of oral anticoagulants for non-valvular atrial fibrillation: A population-based cohort study in primary health care in catalonia
by: Maria Giner-Soriano, et al.
Published: (2023)

Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia
by: Maria Giner-Soriano, et al.
Published: (2023)

Treatment of hypertension during pregnancy: a cohort of pregnancy episodes from the SIDIAP database, Catalonia, Spain
by: Ainhoa Gomez-Lumbreras, et al.
Published: (2024)

Outcomes of COVID-19 Infection in People Previously Vaccinated Against Influenza: Population-Based Cohort Study Using Primary Health Care Electronic Records
by: Maria Giner-Soriano, et al.
Published: (2022)

Correlation between Previous Antibiotic Exposure and COVID-19 Severity. A Population-Based Cohort Study
by: Carl Llor, et al.
Published: (2021)

Urinary Tract Infections in Men in Primary Care in Catalonia, Spain
by: Silvia Fernández-García, et al.
Published: (2023)

Drug Exposure During Pregnancy: A Case-Control Study from a Primary Care Database
by: Ainhoa Gomez-Lumbreras, et al.
Published: (2024)

Antimicrobial Agent Use for Urinary Tract Infection in Long-Term Care Facilities in Spain: Results from a Retrospective Analytical Cohort Analysis
by: Priscila Matovelle, et al.
Published: (2024)

Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain
by: Sánchez-Cenizo L, et al.
Published: (2019)

What Is Valued Most by Patients With Type 2 Diabetes Mellitus When Selecting Second-Line Antihyperglycemic Medications in China
by: Shimeng Liu, et al.
Published: (2021)

Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar
by: Nang Thu Thu Kyaw, et al.
Published: (2017)

Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study
by: José Ríos, et al.
Published: (2024)

Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study
by: Timothy P. Hanrahan, et al.
Published: (2022)

TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure
by: Jin Lei, et al.
Published: (2022)

Second-line treatment options in hepatocellular carcinoma
by: Donatella Marino, et al.
Published: (2019)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
by: Samsuddin Khan, et al.
Published: (2014)

Cost containment by peer prior authorization program for second line treatment in patients with retinal disease
by: Amir Rosenblatt, et al.
Published: (2021)

Clinical Efficacy and Safety of an Immune Checkpoint Inhibitor in Combination with Regorafenib Therapy as Second-Line Regimen for Patients with Unresectable Hepatocellular Carcinoma
by: Li J, et al.
Published: (2023)

Physicians' choices in the first- and second-line management of type 2 diabetes in the Kingdom of Saudi Arabia
by: Khalid Al-Rubeaan, et al.
Published: (2020)

Dolutegravir for second-line treatment: Programmatic implications of new evidence
by: Ying Zhao, et al.
Published: (2022)

Combination of pembrolizumab and lenvatinib in second-line therapy for MSS/pMMR advanced endometrial cancer: literature review and a case report
by: A. D. Darenskaya, et al.
Published: (2024)

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report
by: María Espinosa Bosch, et al.
Published: (2016)

Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma
by: Zhou L, et al.
Published: (2020)

Second-line afatinib administration in an elderly patient with squamous cell carcinoma
by: Hohenforst-Schmidt W, et al.
Published: (2017)

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients
by: Rafael Caparica, et al.
Published: (2019)

Addressing the unmet need in NSCLC progression with advances in second-line therapeutics
by: Kinsley Wang, et al.
Published: (2024)

Analyzing Black Market Sales of the Second-Line ADHD Medication Atomoxetine
by: Sophie A. Roe, et al.
Published: (2023)

Second-generation antipsychotic and diabetes mellitus in children and adolescents
by: Carlo Ripoli, et al.
Published: (2017)

Weight gain rate in the second and third trimesters and fetal growth in women with gestational diabetes mellitus: a retrospective cohort study
by: Miao Hong, et al.
Published: (2022)

Development of a score for early identification of children with Kawasaki disease requiring second-line treatment in multi-ethnic populations in Europe: A multicentre retrospective cohort study
by: Naim Ouldali, et al.
Published: (2022)

"Highly Exposed Chinese Herbal Medicine" Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study
by: Mingqi Wang, et al.
Published: (2021)

Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study
by: Workineh Shibeshi, et al.
Published: (2019)

With Cavalry in 1915 The British Trooper in the Trench Line, Through the Second Battle of Ypres
by: Coleman, Frederic, 1876-

Second-line Drug Resistance Characterization in Mycobacterium tuberculosis by Genotype MTBDRsl Assay
by: Sunil Sethi, et al.
Published: (2020)

Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma
by: Maria João Marques Ribeiro, et al.
Published: (2018)

Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
by: Bo Hyun Kim, et al.
Published: (2021)

The Effect Of Combıned Headgear On Unerupted Second Molars
by: Tülin Uğur Taner, et al.
Published: (1998)

Adherence to newer second‐line oral antidiabetic drugs among people with type 2 diabetes-A systematic review
by: Nynne Sophie Holdt‐Caspersen, et al.
Published: (2024)

IJCM_425A: Outcomes of Second Line Anti-Retroviral Therapy Among a cohort of people living with HIV/AIDS attending an ART Centre in Mangalore
by: Anand Nandita, et al.
Published: (2024)

Psychological and sleep disturbances among first-line, second-line, and at home medical staff during the COVID-19 pandemic in Shanghai, China
by: Ping Wang, et al.
Published: (2022)